An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Live Science on MSN
New blood test aims to spot liver scarring before it paves the way to cancer
Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...
Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results